home / stock / mson / mson news


MSON News and Press, MISONIX Inc. From 01/21/21

Stock Information

Company Name: MISONIX Inc.
Stock Symbol: MSON
Market: NASDAQ
Website: misonix.com

Menu

MSON MSON Quote MSON Short MSON News MSON Articles MSON Message Board
Get MSON Alerts

News, Short Squeeze, Breakout and More Instantly...

MSON - Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4

FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financi...

MSON - Misonix to Present at the 39th Annual J.P. Morgan Healthcare Conference

FARMINGDALE, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 39 th Annual J.P....

MSON - Misonix's TheraSkin to be covered by U.S. commercial payer

Misonix ([[MSON]] +0.4%)  has announced that the second largest U.S. Commercial payer will now cover TheraSkin, cellular and tissue-based treatment for all lower extremity dermal wounds, including venous leg ulcers and diabetic foot ulcers.The comp...

MSON - Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives

FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that the second largest U.S. Commercial pay...

MSON - Misonix to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along wit...

MSON - Misonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor Conferences

FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Craig-Hallum and...

MSON - Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q1 2021 Results - Earnings Call Transcript

Misonix, Inc. (MSON) Q1 2021 Results Conference Call November 05, 2020 04:30 PM ET Company Participants Norberto Aja - IR Stavros Vizirgianakis - CEO Joe Dwyer - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Ian Tolle - Canaccord Presentation Operator Good day, ever...

MSON - Misonix Inc (MSON) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool. Misonix Inc (NASDAQ: MSON) Q1 2021 Earnings Call Nov 5, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Misonix Inc (MSON) Q1 2021 Earnings Call Transcript

MSON - MISONIX EPS beats by $0.01, misses on revenue

MISONIX (MSON): FQ1 GAAP EPS of -$0.29 beats by $0.01.Revenue of $12.62M (+59.5% Y/Y) misses by $4.53M.Press Release For further details see: MISONIX EPS beats by $0.01, misses on revenue

MSON - Misonix Fiscal 2021 First Quarter Revenue Rises 59% to $17.7 Million

FARMINGDALE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudi...

Previous 10 Next 10